Cite
HARVARD Citation
Knebelmann, B. et al. (n.d.). FP179BASELINE CHARACTERISTICS IN THE "CARDINAL" TRIAL: A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME. Nephrology dialysis transplantation. p. . [Online].